Trail Ridge Investment Advisors’s Everpure Inc P Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$713K Sell
9,051
-413
-4% -$30.3K 0.3% 53
2026
Q1
$559K Sell
9,464
-443
-4% -$30K 0.24% 66
2025
Q4
$664K Sell
9,907
-2,508
-20% -$210K 0.29% 62
2025
Q3
$1.04M Buy
12,415
+401
+3% +$26.7K 0.47% 49
2025
Q2
$715K Sell
12,014
-931
-7% -$46.3K 0.34% 54
2025
Q1
$573K Buy
12,945
+943
+8% +$56.9K 0.3% 63
2024
Q4
$737K Buy
12,002
+152
+1% +$8.47K 0.35% 59
2024
Q3
$621K Sell
11,850
-310
-3% -$17.5K 0.3% 65
2024
Q2
$781K Buy
12,160
+1,166
+11% +$67.5K 0.4% 54
2024
Q1
$572K Buy
10,994
+2,155
+24% +$96.2K 0.32% 64
2023
Q4
$315K Sell
8,839
-581
-6% -$20.4K 0.19% 86
2023
Q3
$336K Buy
9,420
+2,140
+29% +$79.4K 0.23% 81
2023
Q2
$268K Sell
7,280
-1,108
-13% -$31.4K 0.17% 104
2023
Q1
$214K Buy
+8,388
New +$226K 0.14% 112

Other funds holding P

Trail Ridge Investment Advisors's P Position: Q2 2026 in Review

Trail Ridge Investment Advisors reduced its Everpure Inc (P) stake by 4.4% in Q2 2026, selling an estimated $30.3K and leaving 9,051 shares worth $713K. The position accounts for 0.3% of the portfolio, ranked #53.

Trail Ridge Investment Advisors first reported a position in P in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.04M in Q3 2025. 814 funds tracked by Wall St. Rank hold P as of Q2 2026.

  • Trail Ridge Investment Advisors held 9,051 shares of Everpure Inc worth $713K as of Q2 2026.
  • Trail Ridge Investment Advisors sold 413 Everpure Inc shares in Q2 2026, an estimated $30.3K.
  • Everpure Inc made up 0.3% of Trail Ridge Investment Advisors's portfolio in Q2 2026, its #53 holding.
  • Trail Ridge Investment Advisors first reported a position in Everpure Inc in Q1 2023 and has held it in 14 quarters since.
  • Trail Ridge Investment Advisors's Everpure Inc position peaked at $1.04M in Q3 2025.
  • 814 funds tracked by Wall St. Rank held Everpure Inc as of Q2 2026.

Based on Trail Ridge Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.